Cargando…
Effect size of lithium, carbamazepine, and sodium valproate in child and adolescent bipolar 1 disorder during manic phase: A prospective open-label study
AIM: The aim was to evaluate the “effect size (ES),” tolerability, and acceptability of lithium, carbamazepine, and sodium valproate in the acute phase treatment of pediatric Bipolar 1 disorder patients during manic phase. MATERIALS AND METHODS: This hospital-based, prospective, open-label study inc...
Autores principales: | Singh, Rakesh Kumar, Sinha, Vinod Kumar, Chaudhury, Suprakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660003/ https://www.ncbi.nlm.nih.gov/pubmed/33223710 http://dx.doi.org/10.4103/ipj.ipj_3_19 |
Ejemplares similares
-
Auswirkungen von Lithium, Valproat, Carbamazepin und Antipsychotika auf die Kognition bei bipolarer Störung – ein systematisches Review
por: Leopold, Sophie, et al.
Publicado: (2023) -
For the love of all that is holy, stop prescribing sodium valproate and carbamazepine together
por: Jawaid, Wajid
Publicado: (2023) -
THE USE OF CARBAMAZEPINE IN PATIENTS WITH MANIC DEPRESSIVE ILLNESS
por: Sethi, B.B., et al.
Publicado: (1983) -
The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
por: Findling, Robert L, et al.
Publicado: (2014) -
Study of Visual Function in Adult Epileptic Patients on Sodium Valproate or Carbamazepine Monotherapy
por: Matthew, Tong Jong Haw, et al.
Publicado: (2019)